ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pupafly
|
5.4K |
2.7M |
21 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
5.4K
|
2.7M
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Pupafly
|
1.0K |
392K |
3 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
392K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
Pupafly
|
905 |
286K |
3 |
06/03/23 |
06/03/23 |
ASX - By Stock
|
905
|
286K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
2 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change of Director's Interest Notice
|
|
Pupafly
|
66 |
29K |
3 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
66
|
29K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Pupafly
|
5.4K |
2.7M |
4 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
5.4K
|
2.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pupafly
|
9.9K |
3.0M |
1 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.9K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pupafly
|
9.9K |
3.0M |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.9K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pupafly
|
9.9K |
3.0M |
0 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.9K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pupafly
|
9.9K |
3.0M |
0 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.9K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pupafly
|
9.9K |
3.0M |
2 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.9K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Pupafly
|
9.9K |
3.0M |
0 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
9.9K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
Pupafly
|
321 |
103K |
3 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
321
|
103K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
Pupafly
|
1.5K |
506K |
0 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
1.5K
|
506K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast hit with 4th shareholder class action
|
|
Pupafly
|
257 |
78K |
5 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
257
|
78K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022 - Momma says life is like a box of chocolates
|
|
Pupafly
|
222 |
57K |
2 |
03/01/22 |
03/01/22 |
ASX - By Stock
|
222
|
57K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
New Covid 19 treatment
|
|
Pupafly
|
444 |
92K |
0 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
444
|
92K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
New Covid 19 treatment
|
|
Pupafly
|
444 |
92K |
2 |
27/09/21 |
27/09/21 |
ASX - By Stock
|
444
|
92K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
5 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
7 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
4 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
4 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
3 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
3 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
America desperately needs a much better F.D.A.
|
|
Pupafly
|
4 |
1.8K |
1 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
4
|
1.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
Pupafly
|
206 |
62K |
3 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
206
|
62K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2021 Full Year Financial Results Webcast
|
|
Pupafly
|
195 |
64K |
6 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
195
|
64K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Pupafly
|
10K |
3.0M |
4 |
30/08/21 |
30/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
Pupafly
|
516 |
156K |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
516
|
156K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Growing Confidence on COVID-19 Application
|
|
Pupafly
|
344 |
100K |
2 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
344
|
100K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Pupafly
|
76 |
15K |
0 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
76
|
15K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Pupafly
|
76 |
15K |
1 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
76
|
15K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Pupafly
|
76 |
15K |
2 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
76
|
15K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
contribution/s so far and what can we use
|
|
Pupafly
|
76 |
15K |
1 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
76
|
15K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
1 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
30 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
30
|
|
ASX - By Stock
|
MSB |
Re:
MSB - key dates to watch for
|
|
Pupafly
|
58 |
28K |
4 |
22/08/21 |
22/08/21 |
ASX - By Stock
|
58
|
28K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
0 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Pupafly
|
4.7K |
1.1M |
3 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Trading Halt on Announcement
|
|
Pupafly
|
20 |
6.5K |
3 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
20
|
6.5K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
2 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Pupafly
|
17K |
6.7M |
1 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
17K
|
6.7M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
Pupafly
|
340 |
113K |
36 |
20/08/21 |
20/08/21 |
ASX - By Stock
|
340
|
113K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Management Update
|
|
Pupafly
|
157 |
46K |
0 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
157
|
46K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB website indicates Novartis agreement as conditions met.
|
|
Pupafly
|
158 |
46K |
4 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
158
|
46K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Pupafly
|
4.7K |
1.1M |
0 |
19/08/21 |
19/08/21 |
ASX - By Stock
|
4.7K
|
1.1M
|
0
|
|